924 patents currently held
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
318
Ending by 2030
Nov 2026
Next term end
704
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2027 · High confidence
Also notable
Ends Jun 2031 · High confidence
Also notable
Ends Apr 2031 · High confidence
Also notable
Ends Apr 2029 · High confidence
Also notable
Ends Jun 2029 · High confidence
Also notable
Ends Nov 2027 · High confidence
Also notable
Ends Aug 2034 · Medium confidence
Also notable
Ends no later than Jan 2038 · Medium confidence
Reagent Stripe for Test Strip
US 7,727,467
Cited by 251 later US patents, top 5% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Management Method and System for Implementation, Execution, Data Collection, and Data Analysis of a Structured Collection Procedure Which Runs on a Collection Device
US 9,659,037
Cited by 174 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Medical Software Download to Mobile Phone
US 9,811,633
Cited by 65 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Manually Operable Portable Device
US 8,267,921
The most cited patent in this portfolio, cited by 571 later US patents, top 1% of utility patents granted in 2012 in our data. Protection runs to 2029.
Device for Drug Delivery
US 8,465,460
Cited by 179 later US patents, top 5% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Test Strip with Vent Opening
US 7,829,023
Cited by 264 later US patents, top 5% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Insulin Pump and Methods for Operating the Insulin Pump
US 10,251,583
Cited by 62 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2034.
Medical Device for Detecting at Least One Analyte in a Body Fluid
US 11,759,133
Cited by 12 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2038. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 4 to 16, 2026 · next Dec 4
- 13 fees due Jan 7 to 28, 2027 · next Jan 7
- 12 fees due Feb 1 to 28, 2027 · next Feb 1
- 15 fees due Mar 1 to 24, 2027 · next Mar 1
- 16 fees due Apr 1 to 29, 2027 · next Apr 1
- 8 fees due May 3 to 26, 2027 · next May 3
- 20 fees due Jun 1 to 30, 2027 · next Jun 1
- 12 fees due Jul 5 to 28, 2027 · next Jul 5
- 18 fees due Aug 2 to 27, 2027 · next Aug 2
- 13 fees due Sep 3 to 30, 2027 · next Sep 3
- 6 fees due Oct 2 to 30, 2027 · next Oct 2
- 1 fee due Nov 5, 2027The maintenance fee for Implant Needle and Method for Production (US 10,639,070) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
- Oct 23Assignment recorded on 1 record: Galley, Paul Joseph to Roche Diabetes Care, Inc. Recorded Oct 23, 2026, executed Jul 25, 2023. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76477, frame 611.
- 17 of the patents on this record were granted since Aug 22, 2026
- 12 terms have ended since Aug 22, 2026
- Nov 4 US 10,803,989 Medical Software Download to Mobile Phone · term ended
- Oct 29 US 9,139,572 Compounds, Methods, Complexes, Apparatuses and Uses Relating to Stabile Forms of Nad/Nadh · term ended
- Oct 29 US 7,553,615 Compounds, Methods, Complexes, Apparatuses and Uses Relating to Stabile Forms of Nad/Nadh · term ended
- Oct 26 US 7,779,183 Communication Adapter for Ambulant Medical or Therapeutic Devices · term ended
- Oct 22 US 8,043,317 System for Withdrawing Blood · term ended
- Oct 16 US 10,732,140 Portable Analytical Device · term ended
- Oct 11 US 7,556,723 Novel Electrode Design for Biosensor · term ended
- Sep 21 US 8,535,608 Analytical System and Method for Its Operation · term ended
- Sep 9 US 8,828,333 Method for the Production of a Microfluidic System on a Polymer Surface · lapsed on the fee record
- Sep 8 US 10,299,737 System, Tools, Devices and a Program for Diabetes Care · term ended
- Sep 2 US 8,821,442 Infusion system · lapsed on the fee record
- Aug 25 US 7,650,146 System and Method for Monitoring Communication · term ended
What they patent
The largest of its 704 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,663,442 | System and Method for Analyte Measurement Using Dose Sufficiency Electrodes In force · High confidence | In force | High confidence | |
| US 8,997,330 | Layered Sensor for Determining an Analyte Concentration In force · High confidence | In force | High confidence | |
| US 8,187,453 | Triglyceride and Cholesterol Sensing Method and Sensor In force · High confidence | In force | High confidence | |
| US 7,569,126 | System and Method for Quality Assurance of a Biosensor Test Strip In force · High confidence | In force | High confidence | |
| US 8,009,014 | Device and Method for Identifying a User of a Medical Device In force · Medium confidence | In force | Medium confidence | |
| US 7,763,470 | Test Element and Method of Use for Analyzing Body Fluids In force · High confidence | In force | High confidence | |
| US 7,718,439 | System and Method for Coding Information on a Biosensor Test Strip In force · High confidence | In force | High confidence | |
| US 7,435,246 | System and Device for Removing Pharmaceutical Products In force · High confidence | In force | High confidence | |
| US 9,744,295 | Rotatable Infusion Set In force · Medium confidence | In force | Medium confidence | |
| US 7,998,407 | Measurement System for Measuring Substance Concentrations in Liquid Media In force · High confidence | In force | High confidence |
Also on record, not counted in the 924: 8 patents in force now held by others · 675 patents ended · 122 applications pending · 349 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.